$HPPI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Inhibitor Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Inhibitor Therapeutics, Inc.. Get notifications about new insider transactions in Inhibitor Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 19 2021 | HPPI | Inhibitor Therapeu ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Buy | J | 0.00 | 2,240,488 | 0 | 204,083,227 | 201.8 M to 204.1 M (+1.11 %) |
Dec 28 2020 | HPPI | Inhibitor Therapeu ... | Hasara Garrison J. | CFO and Treasurer | Option Exercise | A | 0.03 | 125,000 | 3,875 | 125,000 | |
Dec 28 2020 | HPPI | Inhibitor Therapeu ... | Watson W. Mark | Director | Option Exercise | A | 0.03 | 1,306,452 | 40,500 | 1,306,452 | |
Dec 28 2020 | HPPI | Inhibitor Therapeu ... | Ono Richard Dana | Director | Option Exercise | A | 0.03 | 754,839 | 23,400 | 754,839 | |
Dec 28 2020 | HPPI | Inhibitor Therapeu ... | Peattie Debra | Director | Option Exercise | A | 0.03 | 580,646 | 18,000 | 580,646 | |
Sep 21 2020 | HPPI | Inhibitor Therapeu ... | VIRCA NICHOLAS J | President and CEO | Option Exercise | A | 0.05 | 100,000 | 5,400 | 100,000 | |
Sep 21 2020 | HPPI | Inhibitor Therapeu ... | Hasara Garrison J. | CFO and Treasurer | Option Exercise | A | 0.05 | 100,000 | 5,400 | 100,000 | |
Jul 20 2020 | HPPI | Inhibitor Therapeu ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Buy | J | 0.00 | 3,189,688 | 0 | 201,842,739 | 198.7 M to 201.8 M (+1.61 %) |
Jul 20 2020 | HPPI | Inhibitor Therapeu ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Buy | J | 0.00 | 3,189,688 | 0 | 201,842,739 | 198.7 M to 201.8 M (+1.61 %) |
Mar 24 2020 | HPPI | Inhibitor Therapeu ... | Ono Richard Dana | Director | Option Exercise | A | 0.05 | 1,000,000 | 50,000 | 1,000,000 | |
Mar 24 2020 | HPPI | Inhibitor Therapeu ... | Peattie Debra | Director | Option Exercise | A | 0.05 | 1,000,000 | 50,000 | 1,000,000 | |
Mar 24 2020 | HPPI | Inhibitor Therapeu ... | Martin Robert Daniel | Director | Option Exercise | A | 0.05 | 1,000,000 | 50,000 | 1,000,000 | |
Mar 24 2020 | HPPI | Inhibitor Therapeu ... | Watson W. Mark | Director | Option Exercise | A | 0.05 | 1,500,000 | 75,000 | 1,500,000 | |
Dec 16 2019 | HPPI | Inhibitor Therapeu ... | Peattie Debra | Director | Option Exercise | A | 0.05 | 210,000 | 10,500 | 210,000 | |
Dec 02 2019 | HPPI | Inhibitor Therapeu ... | Hasara Garrison J. | CFO and Treasurer | Buy | P | 0.07 | 13,500 | 945 | 3,972,544 | 4 M to 4 M (+0.34 %) |
Dec 02 2019 | HPPI | Inhibitor Therapeu ... | Hasara Garrison J. | CFO and Treasurer | Buy | P | 0.07 | 13,500 | 945 | 3,972,544 | 4 M to 4 M (+0.34 %) |
Jun 10 2019 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | A | 0.07 | 25,000 | 1,825 | 25,000 | |
Feb 05 2019 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | A | 0.08 | 657,895 | 50,000 | 657,895 | |
Feb 05 2019 | HPPI | HedgePath Pharmace ... | Martin Robert Daniel | Director | Option Exercise | A | 0.08 | 657,895 | 50,000 | 657,895 | |
Feb 05 2019 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | A | 0.08 | 657,895 | 50,000 | 657,895 | |
Feb 05 2019 | HPPI | HedgePath Pharmace ... | MAGRAB E. BRENDAN | Director | Option Exercise | A | 0.08 | 986,842 | 75,000 | 986,842 | |
Jan 24 2019 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Buy | J | 0.00 | 362,121 | 0 | 198,653,051 | 198.3 M to 198.7 M (+0.18 %) |
Dec 26 2018 | HPPI | HedgePath Pharmace ... | Martin Robert Daniel | Director | Grant | A | 0.08 | 60,000 | 4,800 | 116,000 | 56 K to 116 K (+107.14 %) |
Dec 26 2018 | HPPI | HedgePath Pharmace ... | MAGRAB E. BRENDAN | Director | Grant | A | 0.08 | 65,000 | 5,200 | 65,000 | 0 to 65 K |
Dec 19 2018 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Buy | J | 0.00 | 184,798 | 0 | 198,290,930 | 198.1 M to 198.3 M (+0.09 %) |
Aug 31 2018 | HPPI | HedgePath Pharmace ... | Hasara Garrison J. | CFO and Treasurer | Sell | S | 0.27 | 100,000 | 27,000 | 3,959,044 | 4.1 M to 4 M (-2.46 %) |
Jul 06 2018 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Option Exercise | P | 0.28 | 1,739,131 | 478,261 | 1,739,131 | |
Jul 06 2018 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Option Exercise | P | 0.23 | 1,739,131 | 400,000 | 1,739,131 | |
Jul 06 2018 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Option Exercise | P | 0.00 | 2,318,841 | 0 | 5,797,102 | |
Mar 15 2018 | HPPI | HedgePath Pharmace ... | Martin Robert Daniel | Director | Option Exercise | A | 0.27 | 56,000 | 15,243 | 56,000 | |
Mar 15 2018 | HPPI | HedgePath Pharmace ... | Martin Robert Daniel | Director | Option Exercise | A | 0.27 | 253,000 | 68,867 | 253,000 | |
Mar 15 2018 | HPPI | HedgePath Pharmace ... | MAGRAB E. BRENDAN | Chairman of the Boa ... | Option Exercise | A | 0.27 | 345,000 | 93,909 | 345,000 | |
Mar 15 2018 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | A | 0.27 | 56,000 | 15,243 | 56,000 | |
Mar 15 2018 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | A | 0.27 | 253,000 | 68,867 | 253,000 | |
Mar 15 2018 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | A | 0.27 | 76,000 | 20,687 | 76,000 | |
Mar 15 2018 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | A | 0.27 | 253,000 | 68,867 | 253,000 | |
Mar 15 2018 | HPPI | HedgePath Pharmace ... | Hasara Garrison J. | CFO and Treasurer | Option Exercise | A | 0.27 | 260,000 | 70,772 | 260,000 | |
Mar 15 2018 | HPPI | HedgePath Pharmace ... | VIRCA NICHOLAS J | President and CEO | Option Exercise | A | 0.27 | 310,000 | 84,382 | 310,000 | |
Feb 12 2018 | HPPI | HedgePath Pharmace ... | Cross Stefan | Director | Sell | P | 162,660.00 | 600,000 | 97,596,000,000 | 0 | 600 K to 0 (-100.00 %) |
Feb 12 2018 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Buy | P | 162,660.00 | 600,000 | 97,596,000,000 | 198,106,132 | 197.5 M to 198.1 M (+0.30 %) |
Jan 11 2018 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Option Exercise | P | 0.28 | 2,608,696 | 717,391 | 2,608,696 | |
Jan 11 2018 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Option Exercise | P | 0.23 | 2,608,696 | 600,000 | 2,608,696 | |
Jan 11 2018 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Option Exercise | P | 0.00 | 3,478,261 | 0 | 3,478,261 | |
Jul 19 2017 | HPPI | HedgePath Pharmace ... | Martin Robert Daniel | Director | Option Exercise | A | 0.00 | 60,000 | 0 | 60,000 | |
Jul 19 2017 | HPPI | HedgePath Pharmace ... | MAGRAB E. BRENDAN | Chairman of the Boa ... | Option Exercise | A | 0.00 | 65,000 | 0 | 65,000 | |
Jul 12 2017 | HPPI | HedgePath Pharmace ... | HedgePath, LLC | 10% Owner | Sell | S | 0.00 | 2,500,000 | 0 | 79,627,069 | 82.1 M to 79.6 M (-3.04 %) |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | M | 0.00 | 200,000 | 0 | 0 | |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | M | 0.00 | 400,000 | 0 | 0 | |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | M | 0.00 | 300,000 | 0 | 0 | |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Payment of Exercise | F | 0.34 | 79,200 | 26,928 | 553,600 | 632.8 K to 553.6 K (-12.52 %) |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Buy | M | 0.00 | 200,000 | 0 | 632,800 | 432.8 K to 632.8 K (+46.21 %) |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Payment of Exercise | F | 0.34 | 158,400 | 53,856 | 432,800 | 591.2 K to 432.8 K (-26.79 %) |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Buy | M | 0.00 | 400,000 | 0 | 591,200 | 191.2 K to 591.2 K (+209.21 %) |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Payment of Exercise | F | 0.34 | 118,800 | 40,392 | 191,200 | 310 K to 191.2 K (-38.32 %) |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Buy | M | 0.00 | 300,000 | 0 | 310,000 | 10 K to 310 K (+3,000.00 %) |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Hasara Garrison J. | CFO and Treasurer | Option Exercise | M | 0.00 | 3,500,000 | 0 | 0 | |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Hasara Garrison J. | CFO and Treasurer | Option Exercise | M | 0.00 | 3,500,000 | 0 | 0 | |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Hasara Garrison J. | CFO and Treasurer | Payment of Exercise | F | 0.34 | 1,470,478 | 499,963 | 4,059,044 | 5.5 M to 4.1 M (-26.59 %) |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Hasara Garrison J. | CFO and Treasurer | Buy | M | 0.00 | 3,500,000 | 0 | 5,529,522 | 2 M to 5.5 M (+172.45 %) |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Hasara Garrison J. | CFO and Treasurer | Payment of Exercise | F | 0.34 | 1,470,478 | 499,963 | 2,029,522 | 3.5 M to 2 M (-42.01 %) |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Hasara Garrison J. | CFO and Treasurer | Buy | M | 0.00 | 3,500,000 | 0 | 3,500,000 | 0 to 3.5 M |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | VIRCA NICHOLAS J | President and CEO | Option Exercise | M | 0.00 | 15,041,738 | 0 | 0 | |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | VIRCA NICHOLAS J | President and CEO | Payment of Exercise | F | 0.34 | 6,314,219 | 2,146,834 | 8,727,519 | 15 M to 8.7 M (-41.98 %) |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | VIRCA NICHOLAS J | President and CEO | Buy | M | 0.00 | 15,041,738 | 0 | 15,041,738 | 0 to 15 M |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Cross Stefan | Director | Option Exercise | M | 0.00 | 300,000 | 0 | 0 | |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Cross Stefan | Director | Option Exercise | M | 0.00 | 300,000 | 0 | 0 | |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Cross Stefan | Director | Buy | M | 0.00 | 300,000 | 0 | 600,000 | 300 K to 600 K (+100.00 %) |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Cross Stefan | Director | Buy | M | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | M | 0.00 | 150,000 | 0 | 0 | |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | M | 0.00 | 300,000 | 0 | 0 | |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | M | 0.00 | 300,000 | 0 | 0 | |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Payment of Exercise | F | 0.34 | 59,400 | 20,196 | 453,000 | 512.4 K to 453 K (-11.59 %) |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Buy | M | 0.00 | 150,000 | 0 | 512,400 | 362.4 K to 512.4 K (+41.39 %) |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Payment of Exercise | F | 0.34 | 118,800 | 40,392 | 362,400 | 481.2 K to 362.4 K (-24.69 %) |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Buy | M | 0.00 | 300,000 | 0 | 481,200 | 181.2 K to 481.2 K (+165.56 %) |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Payment of Exercise | F | 0.34 | 118,800 | 40,392 | 181,200 | 300 K to 181.2 K (-39.60 %) |
Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Buy | M | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |
Nov 15 2016 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Option Exercise | X | 0.12 | 4,860,000 | 583,200 | 23,504,236 | |
Nov 15 2016 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Option Exercise | X | 0.08 | 333 | 25 | 0 | |
Nov 15 2016 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Option Exercise | X | 0.09 | 4,750,569 | 417,100 | 0 | |
Nov 15 2016 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Buy | X | 0.00 | 4,860,000 | 0 | 197,506,132 | 192.6 M to 197.5 M (+2.52 %) |
Nov 15 2016 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Buy | X | 0.00 | 333 | 0 | 192,646,132 | 192.6 M to 192.6 M (0.00 %) |
Nov 15 2016 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Buy | X | 0.00 | 4,750,569 | 0 | 192,645,799 | 187.9 M to 192.6 M (+2.53 %) |
Nov 07 2016 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Option Exercise | X | 0.08 | 33,333,000 | 2,499,975 | 333 | |
Nov 07 2016 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Option Exercise | X | 0.09 | 5,500,000 | 482,900 | 4,750,569 | |
Nov 07 2016 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Buy | X | 0.00 | 33,333,000 | 0 | 187,895,230 | 154.6 M to 187.9 M (+21.57 %) |
Nov 07 2016 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Buy | X | 0.00 | 5,500,000 | 0 | 154,562,230 | 149.1 M to 154.6 M (+3.69 %) |
Jul 06 2016 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | A | 0.24 | 150,000 | 36,000 | 150,000 | |
Jul 06 2016 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
Jul 06 2016 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | A | 0.24 | 200,000 | 48,000 | 200,000 | |
Jul 06 2016 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
Jul 06 2016 | HPPI | HedgePath Pharmace ... | SEARS SAMUEL P JR | Director | Option Exercise | A | 0.24 | 150,000 | 36,000 | 150,000 | |
Jul 06 2016 | HPPI | HedgePath Pharmace ... | SEARS SAMUEL P JR | Director | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
Jun 20 2016 | HPPI | HedgePath Pharmace ... | HedgePath, LLC | 10% Owner | Sell | S | 0.00 | 2,560,000 | 0 | 82,127,069 | 84.7 M to 82.1 M (-3.02 %) |
Jun 17 2016 | HPPI | HedgePath Pharmace ... | ODONNELL FRANCIS E JR | Executive Chairman | Sell | S | 0.00 | 2,560,000 | 0 | 11,440,000 | 14 M to 11.4 M (-18.29 %) |
Jun 08 2016 | HPPI | HedgePath Pharmace ... | ODONNELL FRANCIS E JR | Executive Chairman | Sell | J | 0.00 | 6,000,000 | 0 | 14,000,000 | 20 M to 14 M (-30.00 %) |
May 27 2016 | HPPI | HedgePath Pharmace ... | Mayne Pharma Group Ltd | 10% Owner | Option Exercise | A | 0.01 | 28,364,236 | 340,371 | 71,948,138 | |
May 27 2016 | HPPI | HedgePath Pharmace ... | Mayne Pharma Group Ltd | 10% Owner | Grant | A | 0.00 | 27,885,000 | 0 | 149,062,230 | 121.2 M to 149.1 M (+23.01 %) |
Sep 14 2015 | HPPI | HedgePath Pharmace ... | HedgePath, LLC | 10% Owner | Buy | C | 0.00 | 82,156,842 | 0 | 104,687,069 | 22.5 M to 104.7 M (+364.65 %) |
Sep 14 2015 | HPPI | HedgePath Pharmace ... | HedgePath, LLC | 10% Owner | Sell | S | 0.00 | 20,000,000 | 0 | 84,687,069 | 104.7 M to 84.7 M (-19.10 %) |
Sep 14 2015 | HPPI | HedgePath Pharmace ... | ODONNELL FRANCIS E JR | Executive Chairman | Buy | P | 0.00 | 20,000,000 | 0 | 20,000,000 | 0 to 20 M |
Aug 18 2015 | HPPI | HedgePath Pharmace ... | Cross Stefan | Director | Option Exercise | A | 0.00 | 300,000 | 0 | 300,000 | |
Aug 18 2015 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | A | 0.00 | 300,000 | 0 | 300,000 | |
Aug 18 2015 | HPPI | HedgePath Pharmace ... | SEARS SAMUEL P JR | Director | Option Exercise | A | 0.00 | 300,000 | 0 | 300,000 | |
Aug 18 2015 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | A | 0.00 | 400,000 | 0 | 400,000 | |
May 19 2015 | HPPI | HedgePath Pharmace ... | Mayne Pharma Group Ltd | 10% Owner | Option Exercise | A | 0.08 | 33,333,333 | 2,500,000 | 43,583,902 | |
May 19 2015 | HPPI | HedgePath Pharmace ... | Mayne Pharma Group Ltd | 10% Owner | Grant | A | 0.00 | 33,333,333 | 0 | 121,177,230 | 87.8 M to 121.2 M (+37.95 %) |
Sep 09 2014 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Buy | P | 0.13 | 10,000 | 1,300 | 10,000 | 0 to 10 K |
Jul 09 2014 | HPPI | HedgePath Pharmace ... | ODONNELL FRANCIS E JR | Executive Chairman | Option Exercise | J | 0.00 | 18,984 | 0 | 64,034 | |
Jul 09 2014 | HPPI | HedgePath Pharmace ... | ODONNELL FRANCIS E JR | Executive Chairman | Option Exercise | J | 0.00 | 4,012 | 0 | 13,532 | |
Jul 09 2014 | HPPI | HedgePath Pharmace ... | ODONNELL FRANCIS E JR | Executive Chairman | Option Exercise | J | 0.88 | 2,716,401 | 2,385,000 | 2,716,401 | |
Jul 09 2014 | HPPI | HedgePath Pharmace ... | ODONNELL FRANCIS E JR | Executive Chairman | Option Exercise | J | 0.88 | 574,032 | 504,000 | 574,032 | |
Jul 09 2014 | HPPI | HedgePath Pharmace ... | ODONNELL FRANCIS E JR | Executive Chairman | Buy | J | 0.00 | 670,510 | 0 | 670,510 | 0 to 670.5 K |
Jul 09 2014 | HPPI | HedgePath Pharmace ... | ODONNELL FRANCIS E JR | Executive Chairman | Buy | J | 0.00 | 141,693 | 0 | 141,693 | 0 to 141.7 K |
Jul 09 2014 | HPPI | HedgePath Pharmace ... | ODONNELL FRANCIS E JR | Executive Chairman | Buy | J | 0.08 | 5,300,000 | 397,500 | 5,970,510 | 670.5 K to 6 M (+790.44 %) |
Jul 09 2014 | HPPI | HedgePath Pharmace ... | ODONNELL FRANCIS E JR | Executive Chairman | Buy | J | 0.08 | 1,120,000 | 84,000 | 1,261,693 | 141.7 K to 1.3 M (+790.44 %) |
Jul 09 2014 | HPPI | HedgePath Pharmace ... | HedgePath, LLC | 10% Owner | Option Exercise | A | 0.00 | 71,636 | 0 | 241,637 | |
Jul 09 2014 | HPPI | HedgePath Pharmace ... | HedgePath, LLC | 10% Owner | Option Exercise | A | 0.88 | 10,250,569 | 9,000,000 | 10,250,569 | |
Jul 09 2014 | HPPI | HedgePath Pharmace ... | HedgePath, LLC | 10% Owner | Grant | A | 0.00 | 2,530,227 | 0 | 2,530,227 | 0 to 2.5 M |
Jul 09 2014 | HPPI | HedgePath Pharmace ... | HedgePath, LLC | 10% Owner | Grant | A | 0.08 | 20,000,000 | 1,500,000 | 22,530,227 | 2.5 M to 22.5 M (+790.44 %) |
Jun 26 2014 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | Director | Option Exercise | A | 0.09 | 1 | 0 | 1 | |
Jun 26 2014 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | Director | Option Exercise | A | 0.00 | 258,363 | 0 | 258,363 | |
Aug 16 2013 | HPPI | HedgePath Pharmace ... | ODONNELL FRANCIS E JR | Executive Chairman | Option Exercise | A | 0.00 | 45,050 | 0 | 45,050 | |
Aug 16 2013 | HPPI | HedgePath Pharmace ... | ODONNELL FRANCIS E JR | Executive Chairman | Option Exercise | A | 0.00 | 9,520 | 0 | 9,520 | |
Aug 16 2013 | HPPI | HedgePath Pharmace ... | HedgePath, LLC | Director | Option Exercise | A | 0.00 | 170,001 | 0 | 170,001 | |
Apr 19 2013 | HPPI | HedgePath Pharmace ... | FREER RICHARD J | Chief Executive Off ... | Buy | J | 0.05 | 2,846,715 | 130,095 | 7,485,141 | 4.6 M to 7.5 M (+61.37 %) |
Apr 19 2013 | HPPI | HedgePath Pharmace ... | SEARS SAMUEL P JR | Director | Buy | J | 0.05 | 372,263 | 17,012 | 1,016,096 | 643.8 K to 1 M (+57.82 %) |
Sep 07 2012 | HPPI | HedgePath Pharmace ... | FREER RICHARD J | Chief Executive Off ... | Buy | J | 0.02 | 2,025,000 | 40,500 | 4,638,426 | 2.6 M to 4.6 M (+77.48 %) |
Jan 21 2010 | HPPI | HedgePath Pharmace ... | D'Sylva Paul | Director | Sell | S | 0.50 | 19,100 | 9,550 | 271,216 | 290.3 K to 271.2 K (-6.58 %) |
Jun 01 2009 | HPPI | HedgePath Pharmace ... | D'Sylva Paul | Director | Buy | P | 0.40 | 12,000 | 4,800 | 290,316 | 278.3 K to 290.3 K (+4.31 %) |
May 18 2009 | HPPI | HedgePath Pharmace ... | D'Sylva Paul | Director | Buy | P | 0.38 | 510 | 194 | 278,316 | 277.8 K to 278.3 K (+0.18 %) |
May 18 2009 | HPPI | HedgePath Pharmace ... | D'Sylva Paul | Director | Buy | P | 0.40 | 2,800 | 1,120 | 277,806 | 275 K to 277.8 K (+1.02 %) |
May 05 2009 | HPPI | HedgePath Pharmace ... | D'Sylva Paul | Director | Buy | P | 0.35 | 23,934 | 8,377 | 275,006 | 251.1 K to 275 K (+9.53 %) |
May 05 2009 | HPPI | HedgePath Pharmace ... | D'Sylva Paul | Director | Buy | P | 0.35 | 500 | 175 | 251,072 | 250.6 K to 251.1 K (+0.20 %) |
May 05 2009 | HPPI | HedgePath Pharmace ... | D'Sylva Paul | Director | Buy | P | 0.35 | 5,866 | 2,038 | 250,572 | 244.7 K to 250.6 K (+2.40 %) |
May 05 2009 | HPPI | HedgePath Pharmace ... | D'Sylva Paul | Director | Buy | P | 0.35 | 19,706 | 6,897 | 244,706 | 225 K to 244.7 K (+8.76 %) |
Jan 06 2009 | HPPI | HedgePath Pharmace ... | REYNOLDS THOMAS R | Executive VP | Grant | A | 0.00 | 25,000 | 0 | 50,719 | 25.7 K to 50.7 K (+97.20 %) |
Jan 06 2009 | HPPI | HedgePath Pharmace ... | HARRIS ROBERT B | President | Grant | A | 0.00 | 25,000 | 0 | 70,064 | 45.1 K to 70.1 K (+55.48 %) |
Jan 06 2009 | HPPI | HedgePath Pharmace ... | FREER RICHARD J | Chief Operating Off ... | Grant | A | 0.00 | 25,000 | 0 | 200,474 | 175.5 K to 200.5 K (+14.25 %) |
Jan 06 2009 | HPPI | HedgePath Pharmace ... | BRENNAN JAMES H | VP Financial Operat ... | Grant | A | 0.00 | 25,000 | 0 | 34,866 | 9.9 K to 34.9 K (+253.40 %) |
Oct 01 2008 | HPPI | HedgePath Pharmace ... | FREER RICHARD J | COO | Buy | P | 0.98 | 5,000 | 4,900 | 180,880 | 175.9 K to 180.9 K (+2.84 %) |
Sep 23 2008 | HPPI | HedgePath Pharmace ... | PharmAust Chemistry Ltd. | 10% Owner | Sell | S | 1.45 | 2,150,000 | 3,117,500 | 0 | 2.2 M to 0 (-100.00 %) |
May 28 2008 | HPPI | HedgePath Pharmace ... | HARRIS ROBERT B | President | Sell | S | 1.59 | 10,000 | 15,850 | 45,064 | 55.1 K to 45.1 K (-18.16 %) |
Apr 17 2008 | HPPI | HedgePath Pharmace ... | REYNOLDS THOMAS R | Secretary | Sell | S | 2.89 | 4,000 | 11,560 | 29,517 | 33.5 K to 29.5 K (-11.93 %) |
Mar 10 2008 | HPPI | HedgePath Pharmace ... | REYNOLDS THOMAS R | Secretary | Grant | A | 0.00 | 1,315 | 0 | 33,517 | 32.2 K to 33.5 K (+4.08 %) |
Mar 10 2008 | HPPI | HedgePath Pharmace ... | FREER RICHARD J | Chairman and COO | Grant | A | 0.00 | 1,315 | 0 | 175,880 | 174.6 K to 175.9 K (+0.75 %) |
Mar 10 2008 | HPPI | HedgePath Pharmace ... | HARRIS ROBERT B | President | Grant | A | 0.00 | 1,315 | 0 | 55,064 | 53.7 K to 55.1 K (+2.45 %) |
Feb 06 2008 | HPPI | HedgePath Pharmace ... | HARRIS ROBERT B | President | Option Exercise | A | 2.48 | 30,000 | 74,400 | 86,562 | |
Feb 06 2008 | HPPI | HedgePath Pharmace ... | REYNOLDS THOMAS R | Vice President | Option Exercise | A | 2.48 | 30,000 | 74,400 | 74,234 | |
Jan 03 2007 | HPPI | HedgePath Pharmace ... | HARRIS ROBERT B | President & CEO | Grant | A | 0.00 | 1,314 | 0 | 53,749 | 52.4 K to 53.7 K (+2.51 %) |